Cleared Traditional

K865014 - LIQUICHEK IMMUNOLOGY CONTROL (HUMAN) LEVELS I & II

K865014 is an FDA 510(k) clearance for LIQUICHEK IMMUNOLOGY CONTROL (HUMAN) LE..., manufactured by Bio-Rad. The device is a Class 1 Immunology device with product code DGR cleared through the Traditional 510(k) pathway after a 17-day FDA review.

K865014 · Bio-Rad · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1987
Decision
17d
Days
Class 1
Risk

K865014 is an FDA 510(k) clearance for the LIQUICHEK IMMUNOLOGY CONTROL (HUMAN) LEVELS I & II. Classified as Whole Human Serum, Antigen, Antiserum, Control (product code DGR), Class I - General Controls.

Submitted by Bio-Rad (Richmond, US). The FDA issued a Cleared decision on January 9, 1987 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5700 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio-Rad devices

FDA 510(k) Submission Details - K865014

510(k) Number K865014 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 1986
Decision Date January 09, 1987
Days to Decision 17 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 105d · This submission: 17d
Pathway characteristics
Predicate-based equivalence.

DGR Device Classification - Class 1, General Controls

Product Code DGR Whole Human Serum, Antigen, Antiserum, Control
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.5700
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - DGR Whole Human Serum, Antigen, Antiserum, Control

Devices cleared under the same product code (DGR) and FDA review panel - the closest regulatory comparables to K865014.
QUALITROL IGAME CONTROLS, LEVELS 1 AND 2
K961544 · Consolidated Technologies, Inc. · Sep 1996
PRECIPATH(R) IM NORMAL & ABNORMAL IMMUNO. CONTROL
K902220 · Boehringer Mannheim Corp. · Sep 1990
RADIOASSAY, CONTROL SERUM I, II, III
K790298 · Kallestad Laboratories, Inc. · Apr 1979
ICS NORMAL CONTROL SERUM
K781355 · Beckman Instruments, Inc. · Aug 1978